Targeting PAK1
p21-Activated kinase 1 (PAK1) has attracted much attention as a potential therapeutic target due to its central role in many oncogenic signaling pathways, its frequent dysregulation in cancers and neurological disorders, and its tractability as a target for small-molecule inhibition. To date, severa...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Revisão |
| Språk: | engelska |
| Publicerad: |
2017
|
| Länkar: | https://doi.org/10.1042/bst20160134 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|